MedtronicTalks

In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management.

Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits.

Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.

Thank you for listening to the Medtronic Podcast.

Subscribe to this podcast on every major podcast platform.

Unlike other businesses at Medtronic, the Mechanical Circulatory Support group isn’t measured by the number of new patients receiving medical devices. Instead, MCS is charged with caring for the nearly 3,000 patients who have already been implanted with Medtronic’s Heartware Ventricular Assist Device (HVAD.) In 2021, Medtronic stopped distributing the HVADs following studies that showed recipients had a higher risk of suffering strokes than those who were implanted with another company’s VAD. But Medtronic’s mission didn’t end with the suspension. In this episode, Raj Thomas, vice president and general manager of MCS, explains how his team continues to support recipients, their caregivers and clinicians to help ensure those heart failure patients can live the fullest lives possible. Thomas details MCS’s steps toward providing support including the organization of a global meeting and the establishment of a patient advisory board.

Thank you to Resonant Link for sponsoring this episode.

Thank you for listening to this episode of the MedtronicTalks Podcast.

Subscribe to this podcast on any major podcast application.

Karen Parkhill assumed the role of chief financial officer at Medtronic six years ago, making her first move into the medical device industry. Over that time, Parkhill has helped oversee many transformations at Medtronic including the reorganization into 20 business units. As CFO, Parkhill also has had a hand in establishing gender equity pay at Medtronic and serves as the Executive Sponsor of the Medtronic PRIDE Employee Resource Group. She’s also active in cultivating and developing a rising number of women executives. In this interview we’ll talk with Karen Parkhill about the progress Medtronic has made in all those efforts and what she expects from the future.

Thank you for listening to the MedtronicTalks Podcast.

Subscribe to this podcast channel on any major podcast player.

Karen Parkhill assumed the role of chief financial officer at Medtronic six years ago, making her first move into the medical device industry. Over that time, Parkhill has helped oversee many transformations at Medtronic including the reorganization into 20 business units. As CFO, Parkhill also has had a hand in establishing gender equity pay at Medtronic and serves as the Executive Sponsor of the Medtronic PRIDE Employee Resource Group. She’s also active in cultivating and developing a rising number of women executives. In this interview, we’ll talk with Karen Parkhill about the progress Medtronic has made in all those efforts and what she expects from the future.

Thank you for listening to the MedtronicTalks Podcast.

Subscribe to this podcast channel on any major podcast application.

Technologies including AI, robotics and customized implants creates new opportunities for Medtronic’s growing Cranial and Spinal Technologies business. In this episode, Skip Kiil, president of the business unit, explains how his group is deploying technology to drive future growth. Kiil, a former professional baseball player before turning to medtech, also shares critical advice to young medical device executives who are looking to gain relevant experience rapidly. This episode is sponsored by Allied Motion Technologies.

Thank you for listening to the MedtronicTalks Podcast.

You can subscribe to this podcast on any major podcast application.

Dan Volz, president of the neurovascular business at Medtronic, lays out the dire facts regarding stroke. Less than 10 percent of the 15 million strokes that occur each year worldwide are treated, and the number of strokes grows by 10% each year. In this episode, we’ll explore Medtronic’s new agreement with Avail Medsystems, which sells access to a network of communication devices that provide audio and video connection to operating rooms. Avail CEO Daniel Hawkins joins in on the conversation explaining how Avail can facilitation collaboration between surgeons, speed training on new life-saving devices, and even help engineers observe procedures so they can develop new critical tools. The pair will discuss how Medtronic is using Avail’s products day-to-day as well as part of the company’s new Co-Lab Platform to help those developing new neurovascular products outside of Medtronic. Thank you to Cretex Medical for sponsoring this episode.

Thank you for listening to the MedtronicTalks Podcast.

You can subscribe to this podcast on any major podcast player.

In this episode, Krista Sugerman, vice President, global marketing & communications at Medtronic’s diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a diabetes diagnosis can take over someone’s life. The company is developing tools to help patients monitor their disease and developing longer-lasting equipment that could make managing the disease less of a burden for people with diabetes. This episode is sponsored by BMP Medical.

Thanks for listening to the MedtronicTalks podcast.

You can subscribe to this podcast on any major podcast player.

In this episode, Mira Sahney, president of the Pelvic Health business at Medtronic, explains how incontinence is a debilitating condition that needs more attention and treatment. The company’s implantable sacral neuromodulation therapy system, InterStim, gives people more control over their condition, enabling them to engage in regular daily activities. Sahney discusses this and the ongoing testing of an implantable tibial neuromodulation device that could strengthen bladder control. Sahney also shares details on her engineering career, which has led her to start two medtech companies. She also recently received the Ferolyn Powell Leadership Award from Medtech Women.

Thank you for listening to the MedtronicTalks podcast.

Subscribe to this podcast on any major podcast application.

This episode shines a light on lung cancer, a deadly killer that isn’t getting the attention it deserves. Dr. William Mayfield, WellStar Health System medical director and former chief surgical officer, says lung cancer kills thousands of people every day – more than most other cancers combined – but isn’t screened for as aggressively. Drawing motivation from a personal loss to lung cancer, Emily Elswick, vice president in the Office of the CEO and former vice president and general manager of Lung Health and Visualization, says we currently have the tools necessary to expand screening, but we need to find the will.

In this episode, George Murgatroyd, vice president and general manager of digital surgery, explains how the Touch Surgery is deploying the first AI-powered surgical video and analytics platform to help surgeons learn and perfect new techniques.

Murgatroyd, who joined Medtronic in 2020 when it acquired the maker of Touch Surgery, explains why the system can be the missing link to improve surgeon performance and patient outcomes. This episode is sponsored by Dassault Systèmes.

Thank you for listening to the MedtronicTalks podcast.

This podcast is available on any major podcast app.